Maxipime
Official product details from Elan Corporation. Includes prescribing information and fact sheet.
http://www.elan.com/therapies/products/maxipime.asp...
|
Cefepime (marketed as Maxipime) Update of Ongoing Safety Review
17 Jun 2009 ... FDA finished its analysis of a possible risk of higher death with cefepime and has determined that the data do not indicate a higher rate of ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...
|
MAXIPIME (cefepime hydrochloride) injection, powder, for solution ...
To reduce the development of drug-resistant bacteria and maintain the effectiveness of MAXIPIME® and other antibacterial drugs, MAXIPIME should be
used only ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=9923...
|
Information for Healthcare Professionals: Cefepime (marketed as ...
17 Jun 2009 ... Early Communication About an Ongoing Safety Review of Cefepime (marketed as Maxipime). The potential for increased mortality was noted in a ...
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInfo...
|
[Cefepime (Maxipime) treatment efficacy in surgical patients ]
Introduced in therapy in the last decade of the XXth Century, Cefepime (Maxipime ) is the most active 4th generation cephalosporin, due to its extended ...
http://www.ncbi.nlm.nih.gov/pubmed/12731215...
|
Cefepime (marketed as Maxipime)
19 Jun 2009 ... Cefepime (marketed as Maxipime). Audience: Healthcare professionals. [UPDATE 05/ 14/2008] FDA is continuing its investigation of a possible ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...
|
First-Time Generic Approvals: Maxipime, Tessalon 200 mg, Vesanoid
29 Jun 2007 ... The FDA has approved generic formulations for cefepime hydrochloride 500 mg, 1-g , and 2-g base/vial for parenteral administration in the ...
http://www.medscape.com/viewarticle/559128...
|
Cefepime (marketed as Maxipime) November 2007
14 Nov 2007 ... Cefepime (marketed as Maxipime) November 2007. Audience: Healthcare professionals. [UPDATE 05/14/2008] FDA is continuing its investigation ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...
|
[Maxipime in the treatment of neonatal sepsis]
The aim of our work was to confirm the effectiveness of the IV generation cephalosporin maxipime. Patients with sepsis, septicaemia (induced by
enterobacter ...
http://www.ncbi.nlm.nih.gov/pubmed/16636392...
|
Cefepime (marketed as Maxipime) Safety Review: An Update
Cefepime (marketed as Maxipime) Safety Review: An Update. 6/17/2009. FDA has finished its analysis of a possible risk of higher death with cefepime, ...
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInfo...
|
